Thirty cases of benign prostatic hyperplasia and 30 cases of prostatic adenocarcinoma were selected and stained by AgNOR (argyrophilic staining of the nucleolar organizer region) method. Specimens were obtained by either prostatectomy (open!TIJR) or needle biopsy of the prostate. In this study, the sections of prostatic adenocarcinoma were reviewed. 6 cases were diagnosed as well-differen...

introduction: green light photo selective vaporization of the prostate (pvp) is a minimally invasive method of treatment for clinical benign prostatic hyperplasia with fewer side effects. the aim of this study is to evaluate the safety, effectiveness and cost analysis of pvp compared with transurethral resection of prostate. methods: a systematic search was done in cochrane, trip database, medl...

conclusions w. coagulans inhibits the development of bph can be useful for the treatment of this condition. results the present study revealed that bph caused elevation of mda levels, suppression of tac levels, and increased pcna expression in the prostate gland. interestingly, in a dose-dependent manner, wce caused decreased mda levels and increased tac levels in the prostate gland, compared t...

background: in order to use international prostate symptom score (ipss) in the iranian population, a valid and reliable persian version of this questionnaire is required. to date, this version of ipss with those characteristics is not available. material and methods: for evaluation of the validity, the original version of ipss (english version) was translated into persian and after 3 weeks was ...

Old intact male dogs are often predisposed to benign prostatic hyperplasia. Both hypertrophy and hyperplasia of prostate gland occur due to hormonal influences. Clinical signs such as haematuria, stranguria and tenesmus are often associated with benign prostatic hyperplasia. A seven year-old local breed intact male dog was presented with a primary complaint of haematuria and stranguria. Diagnos...

OBJECTIVE To assess the role of dutasteride in preventing clinical progression of benign prostatic hyperplasia in asymptomatic men with larger prostates. DESIGN Post hoc analysis of four year, double blind Reduction by Dutasteride of Prostate Cancer Events (REDUCE) study PARTICIPANTS 1617 men randomised to dutasteride or placebo with a prostate size >40 mL and baseline International Prostat...

The metabolism of plasticizing phthalates may correlate with an increased risk benign prostatic hyperplasia in humans. Diethylphthalate (DEHP) and its metabolites interfere sex hormone function, causing inflammation oxidative stress at low doses. effects contribute to the development prostate hyperplasia.